Welcome

Since early in 2008, The Prostate Cancer Roundtable has acted as a forum through which all members of the U.S. prostate cancer advocacy community can act in concert to ensure a shared set of legislative and scientific priorities that affect the prevention, detection of risk, diagnosis, and management of prostate cancer—the most commonly diagnosed form of cancer in men. Our fundamental objective is to ensure that we all work together on political, social, and legislative priorities that will lead to:

  • A major decrease in the annual incidence of newly diagnosed cases of prostate cancer
  • The early diagnosis and optimal treatment of all cases of clinically significant prostate cancer
  • Access to high quality care for all men diagnosed with this disease

To see our current Joint Policy Agenda, just click here.

Who Belongs
to the Roundtable?

The membership of the Prostate Cancer Roundtable includes all of the major, independent U.S.-based prostate cancer advocacy organizations … Learn more …

Support Our
Policy Agenda

The Prostate Cancer Roundtable encourages local and regional prostate cancer-specific organizations and patient groups to support our agenda … Learn more …

What’s on
the “Hot Seat”?

Members of the Roundtable join with other organizations to address the qualifications of the next director of AHRQ. Read the April 2013 letter to Sec. Sebelius here.

Read our response to the USPSTF PCa screening recommendation here. Read more here.